Phosplatin Therapeutics LLC
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Phosplatin Therapeutics LLC chose not to state its revenue in its newest notice of a funding round (Dec 2021).
SEC Form D · Dec 2021
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Dec 2021
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Phosplatin Therapeutics LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Frances Bonham | Executive officer | Dec 2021 |
| Robert Fallon | Executive officer | Dec 2021 |
| Fallon Robert | Executive officer | Aug 2020 |
| Matthew Price | Executive officer | Aug 2020 |
| Charles Stuckey | Director | Dec 2021 |
| Elizabeth Tallett | Director | Dec 2021 |
| John Caouette | Director | Dec 2021 |
| Matthew Price | Director | Dec 2021 |
| Neil Sunderland | Director | Dec 2021 |
| Peter Espig | Director | Dec 2021 |
| Robert Fallon | Director | Dec 2021 |
| Rosita Leong | Director | Dec 2021 |
| Fallon Robert | Director | Aug 2020 |
| John Porter | Director | Aug 2020 |